Polymyalgia rheumatica: Clinical presentation is key to diagnosis and treatment

Brian F. Mandell, MD, PhD
Department of Rheumatic and Immunologic Diseases, Vice-Chairman of Medicine for Education, The Cleveland Clinic Foundation; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, PhD, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Brian F. Mandell, MD, PhD
Department of Rheumatic and Immunologic Diseases, Vice-Chairman of Medicine for Education, The Cleveland Clinic Foundation; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, PhD, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Brian F. Mandell, MD, PhD
Department of Rheumatic and Immunologic Diseases, Vice-Chairman of Medicine for Education, The Cleveland Clinic Foundation; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, PhD, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.